Developmental Research Program

项目摘要/摘要 斯隆纪念医院膀胱癌孢子发育研究计划的目标 凯特琳癌症中心(MSK)将通过以下方式支持尿路上皮癌的创新翻译研究项目 建立快速融资机制。膀胱内孢子的发展研究计划基金 癌症，加上机构资金，将使我们能够通过新的和已建立的项目来支持项目 对于在预防、诊断和治疗方面产生新想法至关重要的研究人员 尿路上皮癌。我们将征求具有翻译潜力的尿路上皮癌试点项目的建议书 更大的MSK社区内的临床和基础研究人员，包括洛克菲勒大学和威尔 康奈尔医学院。经过DRP主任的严格同行审查，内部和外部咨询 董事会和患者代言人，这是这个广泛的发展组合中最有前途的新项目 研究项目将被挑选出来。将优先考虑补充长期研究的项目 孢子的目标和推进我们的翻译研究目标。民政署亦可征集及资助 解决膀胱内MSK孢子的紧急和特定需求的实验或临床倡议 癌症计划或一个独特的研究机会。符合资格的试验计划申请者必须拥有 相关研究领域的MD、MD/PhD或博士学位可被任命为MSK或 附属机构(威尔·康奈尔医学院、洛克菲勒大学)，展示对 从事与尿路上皮癌相关的翻译研究，并同意参与所有相关研究 与MSK孢子相关的会议和活动在膀胱癌的支持期间。《DRP》 致力于遵守和支持MSK政策和程序，以促进多样性和 加强妇女和代表人数不足的少数群体个人的参与。

PROJECT SUMMARY/ABSTRACT The goal of the Developmental Research Program (DRP) of the SPORE in Bladder Cancer at Memorial Sloan Kettering Cancer Center (MSK) is to support innovative translational research projects in urothelial cancer by establishing mechanisms for rapid funding. Developmental Research Program funds in the SPORE in Bladder Cancer, supplemented by institutional funds, will allow us to support projects by new and established investigators that are critical to the generation of new ideas in the prevention, diagnosis, and treatment of urothelial cancer. We will request proposals for urothelial cancer pilot projects with translational potential from clinical and basic investigators within the larger MSK community, including Rockefeller University and Weill Cornell Medical College. After rigorous peer review by the DRP Directors, Internal and External Advisory Boards, and the Patient Advocate, the most promising new projects from this wide portfolio of developmental research projects will be selected. Preference will be given to projects that complement the long-term research goals of the SPORE and advance our translational research objectives. The DRP may also solicit and fund experimental or clinical initiatives that address an urgent and specific need in the MSK SPORE in Bladder Cancer program or a unique research opportunity. Eligible pilot project applicants to the DRP must have an MD, MD/PhD, or PhD degree in a relevant area of research, be appointed as faculty members at MSK or affiliated institution (Weill Cornell Medical College, Rockefeller University), demonstrate commitment to an academic career in translational research related to urothelial cancer, and agree to participate in all relevant conferences and activities related to the MSK SPORE in Bladder Cancer for the duration of support. The DRP is committed to adhering to and supporting the MSK policies and procedures to promote diversity and strengthen the participation of women and individuals from underrepresented minorities.